[1,2,4]Triazolo[4,3-a]pyridine-8-carboxylic acid dihydrate, 95.0%, 250mg

(S)-2-Amino-4-(4-bromophenyl)butanoic acid, 95%, 500mg

(2R,6S)-rel-tert-Butyl 2,6-diethyl-4-oxopiperidine-1-carboxylate, 95.0%, 1g

4,4'-Dipyridyl, 98.0%, 1g

N-((3R,4R)-1,4-dimethylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine, 98%, 10mg

Mandatory signs in accordance with ISO 7010, Protective apron required, 100 mm, 1 piece

N-(2-Hydroxybenzyl)acetamide, 97.0%, 1g

2,3,6-Trifluorobenzaldehyde>98.0%(GC)5g

(R)-1-(2-(TRIFLUOROMETHYL)PHENYL)ETHANAMINE, 95.0%, 100mg

4-Hydroxy-6-oxo-1,6-dihydropyridazine-3-carboxylic acid, 97.0%, 250mg

Dimethyl (4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)phosphonate, 95.0%, 250mg

1-(4-Chloro-phenyl)-4-hydroxy-1H-pyrazole-3-carboxylic acid ethyl ester, 92.0%, 250mg

2,3-Difluorotoluene>98.0%(GC)1g